Signal active
Investment Firm
Overview
Oxford Finance delivers flexible financial solutions to healthcare and life sciences companies worldwide. Their capital provides clients with the fuel needed for innovation and growth.
Highlights
2002
Financial Services
51-100
153
67
92
Late Stage Venture, Early Stage Venture
Private Equity Firm
Location
United States, North America
Contact Information
Social
Profile Resume
Oxford Finance LLC, established in 2002 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture investments across Biotechnology, Health Care, Medical, Financial Services, Venture Capital, FinTech, Banking, Consulting, Finance, Life Science. The organization boasts a portfolio of 153 investments, with an average round size of $55.8M and 92 successful exits. Their recent investments include BioVex, Silicon Valley Bank, Scottish Equity Partners, New Science Ventures, Triathlon Medical Venture Partners. The highest investment round they participated in was $150.2B. Among their most notable exits are BioVex and Silicon Valley Bank. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
Investment portfolio
153
18
67
92
Investments
153
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Nov 16, 2022 | Pearl Street Dental Management | Finance | 115.0M |
May 11, 2023 | Amino | Financial Services | 42.0M |
Jul 26, 2023 | Headspace | Internet | 105.0M |
Jan 02, 2024 | Verona Pharma | Biotechnology | 400.0M |
Exits
92
Funding Timeline
153
0
0
Funding Rounds
153
Oxford Finance LLC has raised 153 rounds. Their latest funding was raised on Jan 02, 2024 from a Post-IPO Debt - Verona Pharma round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Nov 16, 2022 | Debt Financing - Pearl Street Dental Management | - | 115.0M | - |
May 11, 2023 | Debt Financing - Amino | - | 42.0M | - |
Jul 26, 2023 | Debt Financing - Headspace | - | 105.0M | - |
Jan 02, 2024 | Post-IPO Debt - Verona Pharma | - | 400.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.